quinazolines has been researched along with Muscular Dystrophy, Duchenne in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Bidou, L; Bugaud, O; Chirkin, E; Cintrat, JC; Coupet, M; Demais, S; François, P; Hatin, I; Karri, S; Merer, G; Namy, O | 1 |
1 other study(ies) available for quinazolines and Muscular Dystrophy, Duchenne
Article | Year |
---|---|
2-Guanidino-quinazoline promotes the readthrough of nonsense mutations underlying human genetic diseases.
Topics: Cell Line; Codon, Nonsense; Codon, Terminator; Drug Evaluation, Preclinical; Genes, Reporter; Genetic Diseases, Inborn; Gentamicins; Guanidines; High-Throughput Screening Assays; Humans; Muscular Dystrophy, Duchenne; Quinazolines | 2022 |